BioLine RX Ltd
TASE:BLRX
Income Statement
Earnings Waterfall
BioLine RX Ltd
Revenue
|
4.8m
USD
|
Cost of Revenue
|
-3.7m
USD
|
Gross Profit
|
1.1m
USD
|
Operating Expenses
|
-44.1m
USD
|
Operating Income
|
-43m
USD
|
Other Expenses
|
-17.6m
USD
|
Net Income
|
-60.6m
USD
|
Income Statement
BioLine RX Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
N/A
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(17)
|
(15)
|
(14)
|
(15)
|
(17)
|
(18)
|
(18)
|
(17)
|
(16)
|
(16)
|
(15)
|
(16)
|
(17)
|
(18)
|
(19)
|
(22)
|
(25)
|
(27)
|
(27)
|
(26)
|
(26)
|
(25)
|
0
|
(19)
|
(28)
|
(23)
|
(28)
|
(26)
|
(23)
|
(22)
|
(22)
|
(24)
|
(25)
|
(25)
|
(26)
|
(27)
|
(29)
|
(32)
|
(34)
|
(40)
|
(44)
|
|
Selling, General & Administrative |
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(6)
|
(5)
|
0
|
(4)
|
(5)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(11)
|
(15)
|
(20)
|
(27)
|
(31)
|
|
Research & Development |
(12)
|
(10)
|
(9)
|
(10)
|
(12)
|
(12)
|
(12)
|
(12)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(14)
|
(16)
|
(19)
|
(21)
|
(21)
|
(21)
|
(19)
|
(19)
|
0
|
(15)
|
(23)
|
(19)
|
(24)
|
(22)
|
(17)
|
(12)
|
(13)
|
(14)
|
(19)
|
(20)
|
(20)
|
(19)
|
(17)
|
(17)
|
(14)
|
(13)
|
(12)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(17)
N/A
|
(15)
+14%
|
(14)
+5%
|
(15)
-6%
|
(17)
-17%
|
(18)
-2%
|
(18)
-1%
|
(17)
+3%
|
(16)
+6%
|
(16)
+3%
|
(15)
+2%
|
(16)
-6%
|
(17)
-2%
|
(18)
-9%
|
(19)
-7%
|
(22)
-13%
|
(25)
-15%
|
(27)
-5%
|
(27)
-2%
|
(26)
+3%
|
(26)
+3%
|
(25)
+4%
|
0
N/A
|
(19)
N/A
|
(28)
-46%
|
(23)
+19%
|
(28)
-24%
|
(26)
+7%
|
(23)
+13%
|
(22)
+6%
|
(22)
-4%
|
(24)
-7%
|
(25)
-3%
|
(25)
-3%
|
(26)
-4%
|
(27)
-3%
|
(29)
-7%
|
(32)
-10%
|
(34)
-7%
|
(40)
-15%
|
(43)
-9%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
2
|
7
|
3
|
4
|
2
|
2
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
0
|
0
|
(1)
|
3
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
|
Total Other Income |
1
|
(1)
|
(1)
|
2
|
(0)
|
1
|
0
|
1
|
0
|
2
|
3
|
1
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
1
|
1
|
0
|
2
|
0
|
4
|
(0)
|
4
|
3
|
0
|
(6)
|
(11)
|
(10)
|
(10)
|
(2)
|
4
|
5
|
4
|
6
|
1
|
(7)
|
(10)
|
(11)
|
|
Pre-Tax Income |
(17)
N/A
|
(16)
+8%
|
(15)
+1%
|
(11)
+27%
|
(11)
+1%
|
(13)
-20%
|
(14)
-6%
|
(15)
-7%
|
(14)
+4%
|
(14)
+6%
|
(13)
+8%
|
(15)
-22%
|
(16)
-4%
|
(17)
-9%
|
(18)
-7%
|
(21)
-16%
|
(24)
-14%
|
(26)
-6%
|
(26)
+0%
|
(25)
+4%
|
(23)
+7%
|
(23)
+0%
|
0
N/A
|
(16)
N/A
|
(25)
-62%
|
(20)
+20%
|
(27)
-33%
|
(28)
-2%
|
(30)
-8%
|
(34)
-12%
|
(34)
0%
|
(35)
-3%
|
(27)
+22%
|
(22)
+19%
|
(22)
-3%
|
(24)
-5%
|
(25)
-6%
|
(32)
-29%
|
(43)
-34%
|
(52)
-21%
|
(61)
-16%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(17)
|
(16)
|
(15)
|
(11)
|
(11)
|
(13)
|
(14)
|
(15)
|
(14)
|
(14)
|
(13)
|
(15)
|
(16)
|
(17)
|
(18)
|
(21)
|
(24)
|
(26)
|
(26)
|
(25)
|
(23)
|
(23)
|
0
|
(16)
|
(25)
|
(20)
|
(27)
|
(28)
|
(30)
|
(34)
|
(34)
|
(35)
|
(27)
|
(22)
|
(22)
|
(24)
|
(25)
|
(32)
|
(43)
|
(52)
|
(61)
|
|
Net Income (Common) |
(17)
N/A
|
(16)
+8%
|
(15)
+1%
|
(11)
+27%
|
(11)
+1%
|
(13)
-20%
|
(14)
-6%
|
(15)
-7%
|
(14)
+4%
|
(14)
+6%
|
(13)
+8%
|
(15)
-22%
|
(16)
-4%
|
(17)
-9%
|
(18)
-7%
|
(21)
-16%
|
(24)
-14%
|
(26)
-6%
|
(26)
+0%
|
(25)
+4%
|
(23)
+7%
|
(23)
+0%
|
0
N/A
|
(16)
N/A
|
(25)
-62%
|
(20)
+20%
|
(27)
-33%
|
(28)
-2%
|
(30)
-8%
|
(34)
-12%
|
(34)
0%
|
(35)
-3%
|
(27)
+22%
|
(22)
+19%
|
(22)
-3%
|
(24)
-5%
|
(25)
-6%
|
(32)
-29%
|
(43)
-34%
|
(52)
-21%
|
(61)
-16%
|
|
EPS (Diluted) |
-0.66
N/A
|
-0.63
+5%
|
-0.45
+29%
|
-0.32
+29%
|
-0.34
-6%
|
-0.31
+9%
|
-0.26
+16%
|
-0.27
-4%
|
-0.28
-4%
|
-0.25
+11%
|
-0.23
+8%
|
-0.28
-22%
|
-0.28
N/A
|
-0.31
-11%
|
-0.19
+39%
|
-0.2
-5%
|
-0.27
-35%
|
-0.25
+7%
|
-0.24
+4%
|
-0.23
+4%
|
-0.21
+9%
|
-0.17
+19%
|
0
N/A
|
-0.12
N/A
|
-0.17
-42%
|
-0.13
+24%
|
-0.12
+8%
|
-0.09
+25%
|
-0.12
-33%
|
-0.05
+58%
|
-0.05
N/A
|
-0.04
+20%
|
-0.04
N/A
|
-0.03
+25%
|
-0.03
N/A
|
-0.03
N/A
|
-0.03
N/A
|
-0.04
-33%
|
-0.05
-25%
|
-0.06
-20%
|
-0.06
N/A
|